Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koren, R.
Right arrow Articles by Ravid, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koren, R.
Right arrow Articles by Ravid, A.
[Cancer Research 61, 1439-1444, February 15, 2001]
© 2001 American Association for Cancer Research


Endocrinology

Vitamin D Is a Prooxidant in Breast Cancer Cells1

Ruth Koren2, Irit Hadari-Naor, Efrat Zuck, Carmela Rotem, Uri A. Liberman and Amiram Ravid

Basil and Gerald Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus, Petah Tikva, 49100 [R. K., C. R., U. A. L., A. R.], and Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv [R. K., I. H-N., E. Z., U. A. L.], Israel

The anticancer activity of the hormonal form of vitamin D, 1,25-dihydroxyvitamin D [1,25(OH)2D], is associated with inhibition of cell cycle progression, induction of differentiation, and apoptosis. In addition, 1,25(OH)2D3 augments the activity of anticancer agents that induce excessive reactive oxygen species generation in their target cells. This study aimed to find out whether 1,25(OH)2D3, acting as a single agent, is a prooxidant in cancer cells. The ratio between oxidized and reduced glutathione and the oxidation-dependent inactivation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) are considered independent markers of cellular reactive oxygen species homeostasis and redox state. Treatment of MCF-7 breast cancer cells with 1,25(OH)2D3 (10–100 nM for 24–48 h) brought about a maximal increase of 41 ± 13% (mean ± SE) in the oxidized/reduced glutathione ratio without affecting total glutathione levels. The in situ activity of glutathione peroxidase and catalase were not affected by 1,25(OH)2D3, as assessed by the rate of H2O2 degradation by MCF-7 cell cultures. Neither did treatment with 1,25(OH)2D3 affect the levels of glutathione reductase or glutathione S-transferase as assayed in cell extracts. The hormone did not affect overall glutathione consumption and efflux as reflected in the rate of decline of total cellular glutathione after inhibition of its synthesis by buthionine sulfoximine. The extent of reversible oxidation-dependent inactivation of GAPDH in situ was determined by comparing the enzyme activity before and after reduction of cell extracts with DTT. The oxidized fraction was 0.13 ± 0.02 of total GAPDH in control cultures and increased by 56 ± 5.3% after treatment with 1,25(OH)2D3, which did not affect the total reduced enzyme activity. Treatment with 1,25(OH)2D3 resulted in a ~40% increase in glucose-6-phosphate dehydrogenase, the rate-limiting enzyme in the generation of NADPH. This enzyme is induced in response to various modes of oxidative challenge in mammalian cells. Taken together, these findings indicate that 1,25(OH)2D3 causes an increase in the overall cellular redox potential that could translate into modulation of redox-sensitive enzymes and transcription factors that regulate cell cycle progression, differentiation, and apoptosis.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Gago-Dominguez, J. E. Castelao, M. C. Pike, A. Sevanian, and R. W. Haile
Role of Lipid Peroxidation in the Epidemiology and Prevention of Breast Cancer
Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2829 - 2839.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
R. Kodama, T. Kondo, H. Yokote, X. Jing, T. Sawada, M. Hironishi, and K. Sakaguchi
Nuclear localization of glyceraldehyde-3-phosphate dehydrogenase is not involved in the initiation of apoptosis induced by 1-Methyl-4-phenyl-pyridium iodide (MPP+)
Genes Cells, December 1, 2005; 10(12): 1211 - 1219.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Masuda, G. Shima, T. Aiuchi, M. Horie, K. Hori, S. Nakajo, S. Kajimoto, T. Shibayama-Imazu, and K. Nakaya
Involvement of Tumor Necrosis Factor Receptor-associated Protein 1 (TRAP1) in Apoptosis Induced by {beta}-Hydroxyisovalerylshikonin
J. Biol. Chem., October 8, 2004; 279(41): 42503 - 42515.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
B. Wu, A. Ootani, R. Iwakiri, T. Fujise, S. Tsunada, S. Toda, and K. Fujimoto
Ischemic preconditioning attenuates ischemia-reperfusion-induced mucosal apoptosis by inhibiting the mitochondria-dependent pathway in rat small intestine
Am J Physiol Gastrointest Liver Physiol, April 1, 2004; 286(4): G580 - G587.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Danilenko, Q. Wang, X. Wang, J. Levy, Y. Sharoni, and G. P. Studzinski
Carnosic Acid Potentiates the Antioxidant and Prodifferentiation Effects of 1{alpha},25-Dihydroxyvitamin D3 in Leukemia Cells but Does Not Promote Elevation of Basal Levels of Intracellular Calcium
Cancer Res., March 15, 2003; 63(6): 1325 - 1332.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Li, K. Ragheb, G. Lawler, J. Sturgis, B. Rajwa, J. A. Melendez, and J. P. Robinson
Mitochondrial Complex I Inhibitor Rotenone Induces Apoptosis through Enhancing Mitochondrial Reactive Oxygen Species Production
J. Biol. Chem., February 28, 2003; 278(10): 8516 - 8525.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. Lin, Y. Nagai, R. Sladek, Y. Bastien, J. Ho, K. Petrecca, G. Sotiropoulou, E. P. Diamandis, T. J. Hudson, and J. H. White
Expression Profiling in Squamous Carcinoma Cells Reveals Pleiotropic Effects of Vitamin D3 Analog EB1089 Signaling on Cell Proliferation, Differentiation, and Immune System Regulation
Mol. Endocrinol., June 1, 2002; 16(6): 1243 - 1256.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. C. Yeh, P. J. Daschner, J. Lopaczynska, C. J. MacDonald, and H. P. Ciolino
Modulation of Glucose-6-phosphate Dehydrogenase Activity and Expression Is Associated with Aryl Hydrocarbon Resistance in Vitro
J. Biol. Chem., September 7, 2001; 276(37): 34708 - 34713.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.